Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lilli Klug"'
Autor:
Shuai Ye, Dinara Sharipova, Marya Kozinova, Lilli Klug, Jimson D’Souza, Martin G. Belinsky, Katherine J. Johnson, Margret B. Einarson, Karthik Devarajan, Yan Zhou, Samuel Litwin, Michael C. Heinrich, Ronald DeMatteo, Margaret von Mehren, James S. Duncan, Lori Rink
Publikováno v:
JCI Insight, Vol 6, Iss 2 (2021)
Management of gastrointestinal stromal tumors (GISTs) has been revolutionized by the identification of activating mutations in KIT and PDGFRA and clinical application of RTK inhibitors in advanced disease. Stratification of GISTs into molecularly def
Externí odkaz:
https://doaj.org/article/bc77aa077101497c8a5b94060a37a94d
Autor:
James S. Duncan, Yan Zhou, Katherine J. Johnson, Margaret von Mehren, Dinara Sharipova, Marya Kozinova, Ronald P. DeMatteo, Karthik Devarajan, Martin G. Belinsky, Michael Heinrich, Lilli Klug, Samuel Litwin, Shuai Ye, Lori Rink, Jimson W. D’Souza, Margret B. Einarson
Publikováno v:
JCI Insight, Vol 6, Iss 2 (2021)
JCI Insight
JCI Insight
Management of gastrointestinal stromal tumors (GISTs) has been revolutionized by the identification of activating mutations in KIT and PDGFRA and clinical application of RTK inhibitors in advanced disease. Stratification of GISTs into molecularly def
Autor:
Yan Zhou, Katherine J. Johnson, Margret B. Einarson, Lilli Klug, Samuel Litwin, Dinara Sharipova, Shuai Ye, James S. Duncan, Martin G. Belinsky, Michael Heinrich, Lori Rink, Ronald P. DeMatteo, Jimson W. D’Souza, Marya Kozinova, Karthik Devarajan, Margaret von Mehren
Management of gastrointestinal stromal tumor (GIST) has been revolutionized by the identification of activating mutations in KIT and PDGFRA, and the clinical application of receptor tyrosine kinase (RTK) inhibitors in the advanced disease setting. St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f7ba11688abbc6a10b2dbf843667139
https://doi.org/10.1101/2020.06.07.138693
https://doi.org/10.1101/2020.06.07.138693